HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-10-07FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Tivicay PD (dolutegravir sodium) submitted by ViiV Healthcare Company.
-
FDA approval · 2022-10-07FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
FDA approval · 2022-10-07FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TRIUMEQ PD, a fixed-dose combination of abacavir sulfate, dolutegravir sodium, and lamivudine fr…
-
FDA approval · 2022-10-03FDA Approved: TROGARZO — Supplemental Application (Theratechnologies Inc.)
The FDA approved Theratechnologies' supplemental application for TROGARZO (ibalizumab), resulting in updated labeling and/or expanded use fo…
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV [NA]
Clinical trial update on anal HPV tests for screening cell changes in the anus among people with HIV; study status completed with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses [Phase 2, Phase 3]
A pilot Phase 2/3 trial comparing immunogenicity of Fendrix versus double-dose Engerix B in HIV-infected non-responders to standard Hepatiti…
-
FDA approval · 2022-09-29FDA Approved: DARUNAVIR — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for darunavir, establishing a generic version of the HIV-1 protease inhibitor for use in c…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: HIV Reservoir Reduction With Interleukin-2 [Phase 2]
Phase 2 clinical trial evaluating interleukin-2 for reducing HIV reservoirs was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Kenya HIV Self-Testing in PrEP Delivery [NA]
The Kenya-based trial evaluating HIV self-testing within PrEP delivery has completed and posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017) [Phase 3]
Phase 3 results evaluate safety and efficacy of switching to a Doravirine/Islatravir regimen in participants with HIV-1.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy [Phase 1]
Phase 1 trial update for MGD014 in HIV-1-infected individuals on suppressive ART has completed with results posted.
-
FDA approval · 2022-08-31FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for tenofovir disoproxil fumarate filed by Macleods Pharmaceuticals Limited under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection [Phase 3]
Phase 3 feasibility and acceptability study of an individual-level behavioral intervention for individuals with acute/early HIV infection ha…
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018) [Phase 3]
This Phase 3 study evaluates switching HIV-1 patients from Bictegravir/Emtricitabine/Tenofovir Alafenamide to doravirine/islatravir; results…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults [Phase 1]
Phase 1 trial update evaluating safety and immune responses of HIV-1 vaccines M3 and M4 in HIV-infected adults, completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults [Phase 2]
Phase 2 clinical trial assessing safety and immune response of a prime-boost vaccine regimen in HIV-uninfected, vaccine-naive adults.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents [Phase 3]
A Phase 3 trial evaluated the safety and efficacy of the fixed-dose combination dolutegravir/lamivudine (DTG/3TC) in therapy-naive HIV-1-inf…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma [Phase 2]
A Phase 2 trial investigating short term intensified chemo-immunotherapy in HIV-positive patients with Burkitt lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Liraglutide for HIV-associated Neurocognitive Disorder [Phase 4]
Phase 4 trial of liraglutide for HIV-associated neurocognitive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
An update on quality-of-life outcomes for AIDS-related Kaposi sarcoma patients treated with bleomycin and vincristine, with results posted o…
-
FDA approval · 2022-07-25FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs Limited's generic fixed-dose combination tablet of abacavir and lamivudine (ABACAVIR AND LAMIVUDINE) under an Origi…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
This clinical trial update summarizes pharmacokinetic data for antiretroviral drugs during pregnancy and the postpartum period, conducted by…
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana [Phase 4]
Phase 4 clinical trial update on HIV-infected and uninfected pregnant women and child dyads in Botswana; study completed.
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells [Phase 1]
Phase 1 trial in healthy, HIV-1-uninfected adults compared the safety, tolerability, and immunogenicity of CH505TF gp120 produced from stabl…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA) [Phase 3]
A Phase 3 trial evaluating switching virologically suppressed adults with HIV-1 from their current ART regimen to a fixed-dose combination o…